Lungs News and Research

RSS

New roles for growth factors

During embryonic development, nerve cells hesitantly extend tentacle-like protrusions called axons that sniff their way through a labyrinth of attractive and repulsive chemical cues that guide them to their target.

18 Jun 2006

Safe for cystic fibrosis patients to stop using inhaled corticosteroids

In comparison to cystic fibrosis (CF) patients who regularly use inhaled corticosteroid, those who did not use these drugs for six months exhibited no positive or negative effects in terms of major disease factors.

18 Jun 2006

First drug treatment for late-stage cervical cancer approved

FDA has approved a combination of Hycamtin (topotecan hydrochloride) and cisplatin for use as the first drug treatment for women with late-stage cancer of the cervix.

18 Jun 2006

2006 yet 100 die in the Congo from the plague

According to the World Health Organization (WHO), as many as a hundred people have died in a suspected outbreak of pneumonic plague in the Democratic Republic of Congo.

18 Jun 2006

Is there an increased risk of other malignancies in patients with renal cell carcinoma?

There have been conflicting reports in the literature regarding the association of other malignancies with renal cell carcinoma (RCC).

14 Jun 2006

Smokers with wrinkled faces five times at risk of serious lung disease

New research by British scientists has found that heavy wrinkles on the faces of smokers may be an early warning sign of a serious lung disease.

14 Jun 2006

Bortezomib extends lung cancer survival

Adding the new molecularly targeted agent bortezomib to a standard chemotherapy regimen of gemcitabine and carboplatin prolongs survival in patients with advanced non-small cell lung cancer, according to results from a phase II trial.

9 Jun 2006

Markey Cancer Center receives approval to test cancer drug DB-67

Tom Burke died of colon cancer only a few years ago, but not before he helped create a new drug to fight cancer.

8 Jun 2006

Reovirus could be used to treat many forms of advanced cancer

An experimental drug called Reolysin may give hope to patients suffering from advanced cancers, according to research presented at this year's meeting of the American Society of Clinical Oncology (ASCO).

8 Jun 2006

Unbelievable - three die from tuberculosis in the UK

Unbelievable though it may seem in this day and age, three elderly people living in a home for the aged have apparently died of tuberculosis (TB).

8 Jun 2006

Lessons from our patients: development of a warm autopsy program

Thanks in large part to a dying patient's generosity, researchers have for the first time begun to analyze the progression of idiopathic pulmonary fibrosis (IPF), a degenerative illness distinguished by lung inflammation, scarring and diminished breathing capacity that typically leads to death within about five years of diagnosis.

7 Jun 2006

Aggressive invasive treatment of heart attack patients who develop cardiogenic shock could save lives

Despite advances in treatment, people with a heart attack who survive the first hit and get to a hospital remain in danger.

7 Jun 2006

House of Lords says scientific evidence does not support public smoking ban

MPs voted in February by a huge margin to ban smoking from all pubs and private members' clubs in England.

7 Jun 2006

Asbestos linked to cancer of the voice box

According to research carried out by the Institute of Medicine in the U.S. another cancer has been linked to asbestos.

7 Jun 2006

Atorvastatin may increase new blood vessel formation

Systemic sclerosis (SSc), also known as scleroderma, is an uncommon and confounding disease characterized by excessive fibrous tissue formation and vascular abnormalities.

6 Jun 2006

Asthma sufferers reduce need for inhalers by breathing exercises

Scientists in Australia say that people with mild asthma benefit from exercises that focus on shallow breathing through the nose, as well as non-specific upper body exercises, and can reduce the need to use a bronchodilator inhaler by as much as 86 per cent.

6 Jun 2006

Addition of gemcitabine to standard postoperative treatment increased pancreatic cancer patients' survival by 50 percent

Adding the cancer-fighting drug gemcitabine to standard therapy after surgery significantly improves survival for patients with the most common form of pancreatic cancer, according to a new multicenter study led by a University of Maryland radiation oncologist.

6 Jun 2006